原发性腹膜来源的恶性混合 Müllerian 肿瘤。
Malignant mixed müllerian tumor of primary peritoneal origin.
机构信息
School of Medicine, University at Buffalo, Buffalo, NY 14214, USA.
出版信息
Ann Diagn Pathol. 2011 Aug;15(4):273-7. doi: 10.1016/j.anndiagpath.2010.03.004. Epub 2010 Jun 20.
Abstract
The aim of this study was to describe 2 cases of primary peritoneal malignant mixed müllerian tumor (MMMT). Two patients with primary peritoneal MMMT were examined for their clinical and pathologic features. We describe 2 cases of primary peritoneal MMMT in which the carcinomatous and mesenchymal components were readily identifiable, predominantly involving the peritoneum, with no ovarian involvement. The peritoneum and ovaries, with their common embryologic origin, likely account for the peritoneum's ability to undergo a similar malignant transformation, with the resultant genesis of an MMMT of peritoneal origin.
摘要
本研究旨在描述 2 例原发性腹膜恶性混合 Müllerian 肿瘤（MMMT）。对 2 例原发性腹膜 MMMT 患者的临床和病理特征进行了检查。我们描述了 2 例原发性腹膜 MMMT 病例，其中癌性和间充质成分很容易识别，主要累及腹膜，无卵巢受累。腹膜和卵巢具有共同的胚胎起源，可能是腹膜具有类似恶性转化能力的原因，导致腹膜来源的 MMMT 的发生。
相似文献
1
Malignant mixed müllerian tumor of primary peritoneal origin.
Ann Diagn Pathol. 2011 Aug;15(4):273-7. doi: 10.1016/j.anndiagpath.2010.03.004. Epub 2010 Jun 20.
2
Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature.
Cancer. 1994 Aug 1;74(3):854-63. doi: 10.1002/1097-0142(19940801)74:3<854::aid-cncr2820740311>3.0.co;2-r.
3
Extrauterine malignant mixed müllerian tumor of primary peritoneal origin.
Pathology. 1994 Oct;26(4):497-8. doi: 10.1080/00313029400169272.
4
Malignant mixed müllerian tumor of primary mesenteric origin.
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1249-53. doi: 10.1111/j.1525-1438.2005.00192.x.
5
Primary peritoneal malignant mixed mesodermal (Müllerian) tumor.
Tumori. 2009 Jul-Aug;95(4):525-31. doi: 10.1177/030089160909500421.
6
Extra genital heterologous malignant mixed mullerian tumor of primary peritoneal origin.
Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):88-90. doi: 10.4103/0377-4929.44976.
7
Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
Cancer. 2001 Mar 1;91(5):1052-60.
8
Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status.
Diagn Cytopathol. 2009 Apr;37(4):281-5. doi: 10.1002/dc.21001.
9
Primary peritoneal malignant mixed müllerian tumor associated with colonic adenocarcinoma.
Eur J Gynaecol Oncol. 2005;26(5):509-10.
10
Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases.
Gynecol Oncol. 1997 Jun;65(3):523-5. doi: 10.1006/gyno.1997.4716.
引用本文的文献
1
Retroperitoneal primary adenocarcinoma of Mullerian origin: case report with radiology review.
Radiol Case Rep. 2022 Aug 8;17(10):3810-3815. doi: 10.1016/j.radcr.2022.07.041. eCollection 2022 Oct.
2
Primary Pouch of Douglas malignancies: A case series and review of the literature.
Gynecol Oncol Rep. 2017 Jul 15;21:94-97. doi: 10.1016/j.gore.2017.07.007. eCollection 2017 Aug.
3
Primary retroperitoneal müllerian adenocarcinoma: a case report and literature review.
Case Rep Oncol. 2013 Dec 19;6(3):616-21. doi: 10.1159/000357424. eCollection 2013 Sep.
4
The significance of the site of origin in primary peritoneal carcinosarcoma: case report and literature review.
Ecancermedicalscience. 2013 Mar 7;7:295. doi: 10.3332/ecancer.2013.295. Print 2013.
本文引用的文献
1
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
Gynecol Oncol. 2008 Jun;109(3):323-8. doi: 10.1016/j.ygyno.2008.02.024. Epub 2008 Apr 18.
2
Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future.
Oncologist. 2007 Aug;12(8):999-1006. doi: 10.1634/theoncologist.12-8-999.
3
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
J Clin Oncol. 2007 Jul 1;25(19):2755-63. doi: 10.1200/JCO.2006.10.4117.
4
Carcinosarcoma of the ovary.
Int J Gynecol Cancer. 2008 Jan-Feb;18(1):22-9. doi: 10.1111/j.1525-1438.2007.00948.x. Epub 2007 Apr 19.
5
Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience.
Gynecol Oncol. 2007 Jun;105(3):657-61. doi: 10.1016/j.ygyno.2007.01.037. Epub 2007 Mar 28.
6
Malignant mixed müllerian tumor of primary mesenteric origin.
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1249-53. doi: 10.1111/j.1525-1438.2005.00192.x.
7
Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature.
Acta Oncol. 2005;44(7):756-60. doi: 10.1080/02841860500252016.
8
Carcinosarcoma of the ovary-a case series.
Gynecol Oncol. 2006 Jan;100(1):128-32. doi: 10.1016/j.ygyno.2005.07.119. Epub 2005 Oct 5.
9
A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8).
Gynecol Oncol. 2005 Feb;96(2):444-51. doi: 10.1016/j.ygyno.2004.10.020.
10
Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.
Gynecol Oncol. 2004 May;93(2):336-9. doi: 10.1016/j.ygyno.2004.01.007.
Zotero 插件